TOBAM’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-718
| Closed | -$112K | – | 449 |
|
|
2020
Q4 | $112K | Hold |
718
| – | – | 0.01% | 238 |
|
|
2020
Q3 | $82K | Buy |
+718
| New | +$82K | ﹤0.01% | 243 |
|
|
2018
Q2 | – | Sell |
-117,676
| Closed | -$13.1M | – | 175 |
|
|
2018
Q1 | $13.1M | Sell |
117,676
-216,282
| -65% | -$24.1M | 0.54% | 65 |
|
|
2017
Q4 | $39.9M | Sell |
333,958
-32,892
| -9% | -$3.93M | 1.73% | 14 |
|
|
2017
Q3 | $51.5M | Sell |
366,850
-53,965
| -13% | -$7.57M | 1.94% | 10 |
|
|
2017
Q2 | $51.2M | Buy |
420,815
+147,028
| +54% | +$17.9M | 1.91% | 14 |
|
|
2017
Q1 | $33.2M | Buy |
273,787
+199,294
| +268% | +$24.2M | 1.28% | 32 |
|
|
2016
Q4 | $9.11M | Buy |
74,493
+59,692
| +403% | +$7.3M | 0.37% | 64 |
|
|
2016
Q3 | $1.81M | Buy |
+14,801
| New | +$1.81M | 0.07% | 101 |
|